If confirmed that sMICA is directly contributing to the immune evasion present in patients with cancer, targeting specific proteases involved in MICA shedding from cell surfaces or directly blocking sMICA in circulation could be a clinically important strategy to boost the anti-tumor response against cervical cancer. Here, MICA is linked to cervical cancer.